Form 8-K - Current report:
SEC Accession No. 0001104659-25-062576
Filing Date
2025-06-25
Accepted
2025-06-25 16:15:50
Documents
13
Period of Report
2025-06-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518834d1_8k.htm   iXBRL 8-K 44820
  Complete submission text file 0001104659-25-062576.txt   261814

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20250623.xsd EX-101.SCH 3892
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gpcr-20250623_def.xml EX-101.DEF 27149
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20250623_lab.xml EX-101.LAB 37086
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20250623_pre.xml EX-101.PRE 25773
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2518834d1_8k_htm.xml XML 6093
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41608 | Film No.: 251073807
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)